Mechanism of and therapeutic strategy for atrial fibrillation associated with diabetes mellitus (Q27014826)

Hairui Li

2

1 reference

Xianwu Lan

3

1 reference

Xianghui Chen

4

1 reference

Aidong Zhang

5

1 reference

Zicheng Li

6

1 reference

language of work or name

1 reference

2013

1 reference

The Scientific World Journal

14 March 2013

8 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

25 June 2019

27 October 2020

3 February 2021

16 September 2022

9 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

25 June 2019

27 October 2020

3 February 2021

16 September 2022

2013

1 reference

page(s)

209428

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

8 references

14 March 2019

22 March 2019

24 March 2019

17 June 2019

25 June 2019

27 October 2020

3 February 2021

on focus list of Wikimedia project

16 September 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

The role of adiponectin in human vascular physiology

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Atherosclerosis Risk in Communities (ARIC) Study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Diabetes mellitus, glycemic control, and risk of atrial fibrillation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Diabetic cardiomyopathy, causes and effects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Cardiac autonomic neuropathy in diabetes: a clinical perspective

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Substrate-specific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Prevalence of abnormal glucose metabolism in atrial fibrillation: a case control study in 75-year old subjects

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Stroke patients with atrial fibrillation have a worse prognosis than patients without: data from the Austrian Stroke registry

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Neurohormonal modulation in cardiovascular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Prolonged P wave dispersion in pre-diabetic patients.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Prevalence of cardiovascular autonomic dysfunction assessed by spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses at various stages of diabetic neuropathy

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Atrial fibrillation and its association with type 2 diabetes and hypertension in a Swedish community

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Risks of cardiovascular events and effects of routine blood pressure lowering among patients with type 2 diabetes and atrial fibrillation: results of the ADVANCE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

The association between cardiac autonomic neuropathy with metabolic and other factors in subjects with type 1 and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

AGEs-RAGE system mediates atrial structural remodeling in the diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Thiazolidinedione use and post-operative atrial fibrillation: a US nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Pioglitazone attenuates inflammatory atrial fibrosis and vulnerability to atrial fibrillation induced by pressure overload in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

The therapeutic strategies of enhancing adiponectin and lowering leptin may be benefit to controlling atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Incipient cardiovascular autonomic imbalance revealed by wavelet analysis of heart rate variability in Type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Atrial fibrillation can cause major hyperglycemia.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3612491

Catheter Ablation of Atrial Fibrillation in Patients with Diabetes Mellitus Type 2: Results from a Randomized Study Comparing Pulmonary Vein Isolation Versus Antiarrhythmic Drug Therapy

28 November 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F209428

The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs

21 January 2018

1 reference

12 December 2020

Thiazolidinediones as novel upstream therapy for atrial fibrillation in diabetic patients: a review of current evidence

1 reference

12 December 2020

Losartan and its metabolite E3174 modify cardiac delayed rectifier K(+) currents

1 reference

12 December 2020

Diabetes Influences the Cardiac Symptoms Related to Atrial Fibrillation

1 reference

12 December 2020

Neuropathy profile of diabetic patients in a pancreas transplantation program

1 reference

12 December 2020

The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)

1 reference

12 December 2020

Intracellular angiotensin II regulates the inward calcium current in cardiac myocytes

1 reference

12 December 2020

Diabetes mellitus and atrial fibrillation: perspectives on epidemiological and pathophysiological links.

1 reference

12 December 2020

What are arrhythmogenic substrates in diabetic rat atria?

1 reference

12 December 2020

Effects of cardioversion of atrial fibrillation on endothelial function in hypertension or diabetes

1 reference

12 December 2020

Safety and efficacy of catheter ablation of atrial fibrillation in patients with diabetes mellitus--single center experience

1 reference

12 December 2020

Influence of diabetes on the maintenance of sinus rhythm after a successful direct current cardioversion in patients with atrial fibrillation

1 reference

12 December 2020

Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE Trial)

1 reference

12 December 2020

The potential role of thiazolidinediones in atrial fibrillation

1 reference

12 December 2020

Beneficial effect of pioglitazone on the outcome of catheter ablation in patients with paroxysmal atrial fibrillation and type 2 diabetes mellitus

1 reference

12 December 2020

PPAR-γ activator pioglitazone prevents age-related atrial fibrillation susceptibility by improving antioxidant capacity and reducing apoptosis in a rat model

1 reference

12 December 2020

Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes

1 reference

12 December 2020